Jérôme Dauba

4.8k citations
46 papers · 3.6k · 4 hit papers · h-index 24

Impact in

Papers in

    • Colorectal Cancer Treatments and Studies 10
    • Cancer Treatment and Pharmacology 6
    • HER2/EGFR in Cancer Research 3
    • Colorectal Cancer Surgical Treatments 3
    • Lung Cancer Treatments and Mutations 5
    • Gastric Cancer Management and Outcomes 4
    • Prostate Cancer Treatment and Research 4

Jérôme Dauba

44 papers receiving 3.5k citations

Jérôme Dauba's Hit Papers

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial 2022 · 248 citations
2480+5+10Years since publication100200300400500

Peers

Jérôme Dauba
Comparison fields: 5 of 93
  • Geriatrics and Gerontology 333
  • Oncology 1.4k
  • Pulmonary and Respiratory Medicine 1.5k
  • Cancer Research 557
  • Reproductive Medicine 101
Replace Adolfo Gino Favaretto with:
Adolfo Gino Favaretto Italy
Pascaline Boudou‐Rouquette France
Loı̈c Mourey France
Brad Rosbrook United States
Jean-Pierre Droz France
Nicholas R. Maisey United Kingdom
Laurent Cany France
Douglas Jay Weckstein United States
Jacqueline Rose Oates United Kingdom
V. Girre France
Jérôme Dauba relative to Adolfo Gino Favaretto Italy Adolfo Gino Favaretto's profile →
Citations per field
00.5×2×2.7×
Adolfo Gino Favaretto · 1×
Citations per year

Countries citing papers authored by Jérôme Dauba

Since Specialization
Citations

This map shows the geographic impact of Jérôme Dauba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Dauba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Dauba more than expected).

Fields of papers citing papers by Jérôme Dauba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Dauba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Dauba. The network helps show where Jérôme Dauba may publish in the future.

Co-authors

The 25 scholars most cited alongside Jérôme Dauba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jérôme Dauba Line = papers co-authored together Jérôme Dauba links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2013571
2
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial
Hit paper breakdown →
2011440
3 2012358
4
Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018
Hit paper breakdown →
2020249
5
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
Hit paper breakdown →
2022248
6 2016236
7 2013191
8 2018126
9 2014107
10 2019104
11 2014100
12 2015100
13 201585
14 201179
15 202369
16 202064
17 201455
18 201752
19 201949
20 201838

About Jérôme Dauba

Jérôme Dauba is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Geriatrics and Gerontology, Reproductive Medicine and Dermatology, having authored 46 papers that have together received 3.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers), Gastric Cancer Management and Outcomes (4 papers), Prostate Cancer Treatment and Research (4 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Surgical Treatments (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Geriatrics and Gerontology (333 citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.5k citations), Cancer Research (557 citations) and Reproductive Medicine (101 citations). Jérôme Dauba has collaborated with scholars based in France, Luxembourg and Belgium. Frequent co-authors include Laurent Cany, Pierre Soubeyran, Christelle Blanc-Bisson, J. Ceccaldi, Houede Nadine, Jean‐Frédéric Blanc, Marianne Fonck, M. Rainfray, C. Mertens and Carine A. Bellera. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, The Lancet and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact